Advanced Ultrasound in the Diagnosis of Prostate Cancer

Overview

Journal World J Urol

Specialty Urology

Date 2020 Apr 20

PMID 32306060

Citations 29

Authors

Jean-Michel Correas

Ethan J Halpern

Richard G Barr

Sangeet Ghai

Jochen Walz

Sylvain Bodard

Charles Dariane

Jean de la Rosette

Affiliations

Soon will be listed here.

Abstract

The diagnosis of prostate cancer (PCa) can be challenging due to the limited performance of current diagnostic tests, including PSA, digital rectal examination and transrectal conventional US. Multiparametric MRI has improved PCa diagnosis and is recommended prior to biopsy; however, mp-MRI does miss a substantial number of PCa. Advanced US modalities include transrectal prostate elastography and contrast-enhanced US, as well as improved B-mode, micro-US and micro-Doppler techniques. These techniques can be combined to define a novel US approach, multiparametric US (mp-US). Mp-US improves PCa diagnosis but is not sufficiently accurate to obviate the utility of mp-MRI. Mp-US using advanced techniques and mp-MRI provide complementary information which will become even more important in the era of focal therapy, where precise identification of PCa location is needed.

Citing Articles

Ultrasound radiomics model based on grayscale transrectal ultrasound-guided biopsy for diagnosing prostate cancer and predicting distant metastasis.

Liu J, Xiang Z, Yi C, Yang T, Liu D Int Urol Nephrol. 2025; .

PMID: 39776403 DOI: 10.1007/s11255-025-04366-9.

Comparison of Ga-PSMA PET and mpMRI for prostate cancer local staging: a comprehensive review and direct meta-analysis.

Jin X, Cai Y, Ren X Front Oncol. 2024; 14:1410229.

PMID: 39555446 PMC: 11563965. DOI: 10.3389/fonc.2024.1410229.

Comparative Analysis of the Apparent Diffusion Coefficient and Diffusion Tensor Imaging in the Diagnosis of Prostate Cancer.

Karakoishin K, Zholdybay Z, Ainakulova A, Dauytova Y, Kamhen V Asian Pac J Cancer Prev. 2024; 25(7):2397-2408.

PMID: 39068573 PMC: 11480594. DOI: 10.31557/APJCP.2024.25.7.2397.

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Radiomic Models in Prostate Cancer Prognostication.

Huynh L, Swanson S, Cima S, Haddadin E, Baine M Cancers (Basel). 2024; 16(10).

PMID: 38791977 PMC: 11120365. DOI: 10.3390/cancers16101897.

Toward confident prostate cancer detection using ultrasound: a multi-center study.

Wilson P, Harmanani M, To M, Gilany M, Jamzad A, Fooladgar F Int J Comput Assist Radiol Surg. 2024; 19(5):841-849.

PMID: 38704793 DOI: 10.1007/s11548-024-03119-w.

References

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch M, De Santis M . EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2016; 71(4):618-629. DOI: 10.1016/j.eururo.2016.08.003. View

Hayes J, Barry M . Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA. 2014; 311(11):1143-9. DOI: 10.1001/jama.2014.2085. View

Kelloff G, Choyke P, Coffey D . Challenges in clinical prostate cancer: role of imaging. AJR Am J Roentgenol. 2009; 192(6):1455-70. PMC: 2893141. DOI: 10.2214/AJR.09.2579. View

Mian B, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian R . Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology. 2002; 60(5):836-40. DOI: 10.1016/s0090-4295(02)01950-7. View

Singh H, Canto E, Shariat S, Kadmon D, Miles B, Wheeler T . Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol. 2004; 171(5):1850-4. DOI: 10.1097/01.ju.0000119667.86071.e7. View

Delongchamps N, Haas G . Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol. 2009; 6(12):645-52. DOI: 10.1038/nrurol.2009.213. View

Giannarini G, Autorino R, Di Lorenzo G . Saturation biopsy of the prostate: why saturation does not saturate. Eur Urol. 2009; 56(4):619-21. DOI: 10.1016/j.eururo.2009.03.044. View

Ashley R, Inman B, Routh J, Mynderse L, Gettman M, Blute M . Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2007; 53(5):976-81. DOI: 10.1016/j.eururo.2007.10.049. View

Nougaret S, Robertson N, Pernicka J, Molinari N, Hotker A, Ehdaie B . The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer. Abdom Radiol (NY). 2017; 42(7):1968-1974. PMC: 5537601. DOI: 10.1007/s00261-017-1086-7. View

10.

Bloom J, Hale G, Gold S, Rayn K, Smith C, Mehralivand S . Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy. J Urol. 2018; 201(1):84-90. PMC: 8274955. DOI: 10.1016/j.juro.2018.07.051. View

11.

Richenberg J, Logager V, Panebianco V, Rouviere O, Villeirs G, Schoots I . The primacy of multiparametric MRI in men with suspected prostate cancer. Eur Radiol. 2019; 29(12):6940-6952. PMC: 6828624. DOI: 10.1007/s00330-019-06166-z. View

12.

Faria R, Soares M, Spackman E, Ahmed H, Brown L, Kaplan R . Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). Eur Urol. 2017; 73(1):23-30. PMC: 5718727. DOI: 10.1016/j.eururo.2017.08.018. View

13.

Rouviere O, Puech P, Renard-Penna R, Claudon M, Roy C, Mege-Lechevallier F . Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2018; 20(1):100-109. DOI: 10.1016/S1470-2045(18)30569-2. View

14.

Vargas H, Akin O, Shukla-Dave A, Zhang J, Zakian K, Zheng J . Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology. 2012; 265(2):478-87. PMC: 3480819. DOI: 10.1148/radiol.12120041. View

15.

Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A . Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015; 68(6):1045-53. DOI: 10.1016/j.eururo.2015.01.013. View

16.

Johnson D, Raman S, Mirak S, Kwan L, Bajgiran A, Hsu W . Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2018; 75(5):712-720. DOI: 10.1016/j.eururo.2018.11.031. View

17.

Dinh A, Melodelima C, Souchon R, Moldovan P, Bratan F, Pagnoux G . Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate Biopsy. Radiology. 2018; 287(2):525-533. DOI: 10.1148/radiol.2017171265. View

18.

Norberg M, Egevad L, Holmberg L, Sparen P, Norlen B, Busch C . The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997; 50(4):562-6. DOI: 10.1016/S0090-4295(97)00306-3. View

19.

Beerlage H, Aarnink R, Ruijter E, Witjes J, Wijkstra H, Van De Kaa C . Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen. Prostate Cancer Prostatic Dis. 2002; 4(1):56-62. DOI: 10.1038/sj.pcan.4500495. View

20.

Cheng S, Rifkin M . Color Doppler imaging of the prostate: important adjunct to endorectal ultrasound of the prostate in the diagnosis of prostate cancer. Ultrasound Q. 2003; 17(3):185-9. DOI: 10.1097/00013644-200109000-00008. View